BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3266152)

  • 1. Single and multiple dose pharmacokinetics of tenoxicam in the elderly.
    Nilsen OG; Walstad RA; Eckert M; Heizmann P; Bückert A; Am T; Løge I; Unnvik J; Thue E
    Eur J Clin Pharmacol; 1988; 35(5):563-6. PubMed ID: 3266152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma tenoxicam concentrations after single and multiple oral doses.
    Crevoisier C; Heizmann P; Forgo I; Dubach UC
    Eur J Drug Metab Pharmacokinet; 1989; 14(1):23-7. PubMed ID: 2788089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of total and unbound concentrations of tenoxicam in synovial fluid and plasma.
    Day RO; Williams KM; Graham S; Handel M
    Arthritis Rheum; 1991 Jun; 34(6):751-60. PubMed ID: 2053921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of tenoxicam at different dosage regimes.
    Scaglione F; Demartini G; Dugnani S; Fraschini F; Triscari FA
    Farmaco; 1993 Sep; 48(9):1321-5. PubMed ID: 8259988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of cholestyramine on the elimination of tenoxicam and piroxicam.
    Guentert TW; Defoin R; Mosberg H
    Eur J Clin Pharmacol; 1988; 34(3):283-9. PubMed ID: 3260866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neither cimetidine nor probenecid affect the pharmacokinetics of tenoxicam in normal volunteers.
    Day RO; Geisslinger G; Paull P; Williams KM
    Br J Clin Pharmacol; 1994 Jan; 37(1):79-81. PubMed ID: 8148224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenoxicam: acute dose-dependent disposition studies in rats.
    Lopez-Bustamante LG; Troconiz JI; Fos D
    J Pharm Sci; 1993 Aug; 82(8):851-3. PubMed ID: 8377127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease.
    al-Ghamdi MS; al-Mohanna FA; al-Mustafa ZH; al-Saeed IS
    Eur J Clin Pharmacol; 1992; 43(2):197-9. PubMed ID: 1425878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal delivery of tenoxicam in rat.
    Raghavan CV; Abimon VD
    Int J Pharm; 2001 Jun; 221(1-2):227-9. PubMed ID: 11397584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers.
    Nilsen OG; Aasarød K; Widerøe TE; Guentert TW
    Pharmacol Toxicol; 2001 Nov; 89(5):265-72. PubMed ID: 11881981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of tenoxicam in healthy human volunteers.
    Heintz RC; Guentert TW; Enrico JF; Dubach UC; Brandt R; Jeunet FS
    Eur J Rheumatol Inflamm; 1984; 7(2):33-44. PubMed ID: 6336292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenoxicam i.v. in major gynaecological surgery--pharmacokinetic, pain relief and haematological effects.
    Jones RD; Miles W; Prankerd R; Lang C; Chilvers M; Lo SK
    Anaesth Intensive Care; 2000 Oct; 28(5):491-500. PubMed ID: 11094663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenoxicam concentrations in synovium and joint cartilage in humans.
    Bannwarth B; Netter P; Lapicque F; Mainard D; Fener P; Gillet P; Gaucher A
    Agents Actions; 1991 Mar; 32(3-4):295-8. PubMed ID: 1862747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenoxicam used as a parenteral formulation for acute pain in rheumatic conditions.
    Jeunet F; Enz W; Guentert T
    Scand J Rheumatol Suppl; 1989; 80():59-61. PubMed ID: 2595344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of intramuscularly administered tenoxicam.
    Stebler T; Guentert TW
    Biopharm Drug Dispos; 1993 Aug; 14(6):483-90. PubMed ID: 8218966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of liver cirrhosis upon the pharmacokinetics of tenoxicam.
    Crevoisier C; Zaugg PY; Heizmann P; Meyer J
    Int J Clin Pharmacol Res; 1989; 9(5):327-34. PubMed ID: 2625372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview on the pharmacokinetics of tenoxicam.
    Guentert TW; Heintz RC; Joly R
    Eur J Rheumatol Inflamm; 1987; 9(2):15-25. PubMed ID: 3329107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single and multiple oral dose pharmacokinetics of tenoxicam in the elderly.
    Bird HA; Francis RJ; Le Gallez P; Hill J; Dixon JS; Allen JG; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):60-9. PubMed ID: 3879831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam.
    Benveniste C; Striberni R; Dayer P
    Eur J Clin Pharmacol; 1990; 38(6):547-9. PubMed ID: 2373127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.